Home › Encyclopedia › Larazotide: What It Is And Research Status
Research / Unapproved

Larazotide: What It Is And Research Status

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC32H55N9O10
Molecular weight725.8 g/mol
Registered trials29
PubChem CID9810532

Overview

Anyone researching larazotide wants to know whether it is an approved treatment or still experimental. Larazotide remains an investigational compound: it has not received FDA approval and carries no approved drug label.

Key takeaways

  • Larazotide is an investigational peptide compound, not an FDA-approved drug.
  • No approved label, brand name, or indication currently exists for larazotide.
  • The compound has a molecular formula of C32H55N9O10 and a molecular weight of about 725.8.
  • Larazotide is registered across 29 clinical trials in public trial databases.
  • Any use outside of a clinical trial setting falls outside approved medical practice.

What larazotide is

Larazotide is a synthetic peptide identified in chemical databases under PubChem CID 9810532. It has not been reviewed or approved by the FDA, and there is no official prescribing label describing an approved indication, mechanism, or dosing for it. Because no label exists, no verified mechanism of action or approved use can be reported here.

Trial footprint

Public registries list 29 total clinical trials associated with larazotide research. This figure reflects the count of registered studies rather than any conclusion about safety or effectiveness, since investigational compounds are studied specifically because their benefit and risk profile are not yet established.

FAQ

Is larazotide FDA-approved?
No. Larazotide does not have an FDA-approved label, brand name, or approved indication. It remains classified as an investigational compound studied in clinical research settings.
What is larazotide made of?
Larazotide is a synthetic peptide with the molecular formula C32H55N9O10 and a molecular weight of approximately 725.8. It is catalogued in PubChem under CID 9810532.
How many clinical trials have studied larazotide?
Public trial registries list 29 total studies associated with larazotide. This number reflects registered trial activity, not proof of any specific outcome or approval status.
Does larazotide have known side effects?
There is no FDA-reported adverse event data available for larazotide in the sources reviewed here. Because it is investigational, its full safety profile has not been established through an approved label.
Can larazotide be used outside of research studies?
Larazotide has no approved medical use, so any use outside of a registered clinical trial falls outside standard approved practice. Its risks and benefits are still being studied.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem ClinicalTrials.gov ChEMBL

Updated 2026-08-03